The 2015 final academic seminar of the Taiwan Association of Clinical Pathology Laboratory Medicine ended successfully on October 25, on the same day, the company’s two main detection reagents Onko-SureDR-70 ELISA detection and Cervi-M cervical cancer methylation gene detection were exhibited. The company’s special display of the latest testing project Cervi-M cervical cancer methylation gene test, because of the detection convenience, high sensitivity and high specificity, has been highly affirmed by physicians, the whole day of the exhibition also thanks to colleagues for their enthusiastic participation, the exhibition was a complete success!
